Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of pazopanib hydrochloride in stage IV renal cell carcinoma completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Pazopanib hydrochloride (pazopanib)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-04-05